Clinical Trials Browser

NIH × Melanoma × Muromonab-CD3 × Clear all

NCT00080353 2012-06-14

Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

Phase 2 Completed

Melanoma